Aurobindo Pharma Announcements
Intimation of closure of trading window
24 Dec, 2025 | 11:59am • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about acquisition of additional 20% stake in Luoxin Aurovitas Pharma (Chengdu) Co. Ltd, China, a joint venture company
23 Dec, 2025 | 02:06pm • Source: NSE
Intimation of acquisition of additional 20% stake in Luoxin Aurovitas (Chengudu) Co.Ltd, China, a Joint Venture company.
23 Dec, 2025 | 01:28pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about completion of US FDA Inspection at Unit-IV of APL Healthcare Limited, a wholly owned subsidiary of the...
18 Dec, 2025 | 10:11am • Source: NSE
Intimation of completion of US FDA inspection at Unit-IV of APL Healthcare Limited Limited, a wholly owned subsidiary of the Company.
18 Dec, 2025 | 10:06am • Source: BSE
Intimation of investor meet.
15 Dec, 2025 | 02:33pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange a copy of Notice published in Newspapers
02 Dec, 2025 | 11:26am • Source: NSE
Submission of notice published in newspapers.
02 Dec, 2025 | 11:13am • Source: BSE
Submission of newspaper publication.
27 Nov, 2025 | 12:09pm • Source: BSE
Intimation of completion of US FDA inspection of Unit II of Eugia Pharma Specialities Limited, Biwadi, a wholly owned subsidiary of the Company.
14 Nov, 2025 | 04:06pm • Source: BSE
Intimation of investors meeting.
14 Nov, 2025 | 11:49am • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about classification of US FDA Inspection at Unit-I of Apitoria Pharma Private Limited as VAI
14 Nov, 2025 | 10:56am • Source:
Intimation of classification of US FDA inspection at Unit-1 of Apitoria Pharma Private Limited.
14 Nov, 2025 | 10:31am • Source: BSE
Submission of earning call transcript.
11 Nov, 2025 | 05:01pm • Source: BSE
Submission of newspaper publication of unaudited financial results.
07 Nov, 2025 | 02:14pm • Source: BSE
Press release on unaudited financial results for the second quarter and half year ended 30.09.2025.
05 Nov, 2025 | 08:03pm • Source: BSE
Presentation on Unaudited Financial Results of the Company for the second quarter and half year ended 30.09.2025
05 Nov, 2025 | 08:00pm • Source: BSE
The Board of Directors of the Company at its meeting held today, November 5, 2025, has, inter alia, considered and approved the standalone and consolidated...
05 Nov, 2025 | 07:52pm • Source: BSE
Announcement of change in Senior Management Personnel.
04 Nov, 2025 | 12:57pm • Source: BSE
Submission of clarification with reference to movement of volume.
30 Oct, 2025 | 03:23pm • Source: BSE